metoprolol tartrate
metoprolol tartrate is listed in the FDA National Drug Code directory with 37 NDC codes, marketed under brand names including Metoprolol, Metoprolol Tartrate, METOPROLOL TARTRATE. Available dosage forms: injection, tablet, film coated, tablet, injection, solution, powder.
Drug Details
- Generic Name
- metoprolol tartrate
- Brand Names
- Metoprolol, Metoprolol Tartrate, METOPROLOL TARTRATE, Lopressor
- Application Number
- ANDA078950
- Sponsor
- Baxter Healthcare Corporation
- NDC Codes
- 37
- Dosage Forms
- INJECTION, TABLET, FILM COATED, TABLET, INJECTION, SOLUTION, POWDER
- Routes
- INTRAVENOUS, ORAL
- Active Ingredients
- METOPROLOL TARTRATE
Indications and Usage
INDICATIONS AND USAGE Hypertension Metoprolol tartrate tablets are indicated for the treatment of hypertension. They may be used alone or in combination with other antihypertensive agents. Angina Pectoris Metoprolol tartrate tablets are indicated in the long-term treatment of angina pectoris. Myocardial Infarction Metoprolol tartrate tablets are indicated in the treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality when used alone or in conjunction with intravenous metoprolol. Oral Metoprolol tartrate tablets therapy can be initiated after intravenous metoprolol therapy or, alternatively, oral treatment can begin within 3 to 10 days of the acute event. (See DOSAGE AND ADMINISTRATION , , and ).